The genome of Europe project for Pan-European population genomics Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs to invest in creating genomics data to secure national resilience and European leadership. Europe and its Member States face sustained pressure from ageing populations, rising expenditure on chronic disease, global competition in biotechnology, and rapid advances in artificial intelligence (AI)-driven healthcare. Chronic diseases increase with old age and account for the majority of national health spending. Modelling shows that even modest improvements in prevention and earlier intervention could translate into preventing premature deaths and multi-billion-euro long-term savings for national budgets. (1,2)
A Uitterlinden (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: